CA2455248A1 - Administration par voie orale de r-albuterol pour lutter contre l'obesite - Google Patents

Administration par voie orale de r-albuterol pour lutter contre l'obesite Download PDF

Info

Publication number
CA2455248A1
CA2455248A1 CA002455248A CA2455248A CA2455248A1 CA 2455248 A1 CA2455248 A1 CA 2455248A1 CA 002455248 A CA002455248 A CA 002455248A CA 2455248 A CA2455248 A CA 2455248A CA 2455248 A1 CA2455248 A1 CA 2455248A1
Authority
CA
Canada
Prior art keywords
obese
increase
salbutamol
albuterol
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002455248A
Other languages
English (en)
Inventor
Alexander Zolotoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002455248A priority Critical patent/CA2455248A1/fr
Priority to PCT/CA2005/000086 priority patent/WO2005072714A1/fr
Publication of CA2455248A1 publication Critical patent/CA2455248A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
CA002455248A 2004-01-29 2004-01-29 Administration par voie orale de r-albuterol pour lutter contre l'obesite Abandoned CA2455248A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002455248A CA2455248A1 (fr) 2004-01-29 2004-01-29 Administration par voie orale de r-albuterol pour lutter contre l'obesite
PCT/CA2005/000086 WO2005072714A1 (fr) 2004-01-29 2005-01-26 Administration orale de r-albuterol contre l'obesite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002455248A CA2455248A1 (fr) 2004-01-29 2004-01-29 Administration par voie orale de r-albuterol pour lutter contre l'obesite

Publications (1)

Publication Number Publication Date
CA2455248A1 true CA2455248A1 (fr) 2005-07-29

Family

ID=34812779

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002455248A Abandoned CA2455248A1 (fr) 2004-01-29 2004-01-29 Administration par voie orale de r-albuterol pour lutter contre l'obesite

Country Status (2)

Country Link
CA (1) CA2455248A1 (fr)
WO (1) WO2005072714A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022254255A1 (fr) * 2021-06-03 2022-12-08 Fundacao D. Anna De Sommerchampalimaud E Dr. Unités neuro-mésenchymes de lutte contre l'ilc2 et l'obésité par l'intermédiaire d'un circuit du cerveau-adipeux

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016033063A1 (fr) * 2014-08-25 2016-03-03 Board Of Supervisors Of Louisiana State Univ. And Agricultural And Mechanical College Compositions aptes à modifier la composition du corps, leurs procédés d'utilisation, et méthodes thérapeutiques les utilisant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8615995D0 (en) * 1986-07-01 1986-08-06 Glaxo Group Ltd Veterinary preparations
DE3855801T2 (de) * 1987-09-15 1997-07-03 Rowett Research Inst Anwendungsgebiete von beta-adrenergenen Agonisten
DK339289D0 (da) * 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
CA2526155A1 (fr) * 2003-05-22 2004-12-02 Basf Aktiengesellschaft Melanges fongicides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022254255A1 (fr) * 2021-06-03 2022-12-08 Fundacao D. Anna De Sommerchampalimaud E Dr. Unités neuro-mésenchymes de lutte contre l'ilc2 et l'obésité par l'intermédiaire d'un circuit du cerveau-adipeux

Also Published As

Publication number Publication date
WO2005072714A1 (fr) 2005-08-11

Similar Documents

Publication Publication Date Title
Hansen et al. The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction
Halpern et al. Treatment of obesity: an update on anti‐obesity medications
Prather et al. Clenbuterol: a substitute for anabolic steroids?
US6224873B1 (en) Regulation of appetite, body weight and athletic function with materials derived from citrus varieties
Collomp et al. Effects of short-term oral salbutamol administration on exercise endurance and metabolism
Nisoli et al. A benefit-risk assessment of sibutramine in the management of obesity
JPH04507091A (ja) 体重減量医薬組成物
Vukovich et al. Caffeine–herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure
Kim et al. Effect of herbal Ephedra sinica and Evodia rutaecarpa on body composition and resting metabolic rate: a randomized, double-blind clinical trial in Korean premenopausal women
Bai et al. The use of lorcaserin in the management of obesity: a critical appraisal
Le Panse et al. Effects of short-term salbutamol ingestion during a Wingate test
US20020058075A1 (en) Methods for inducing weight loss in a human with materials derived from citrus varieties
Allman et al. Fat metabolism and acute resistance exercise in trained women
ES2339908T3 (es) Regulacion del peso corporal con materiales derivados de variedades del genero de citricos.
Wellman A review of the physiological bases of the anorexic action of phenylpropanolamine (d, l-norephedrine)
WO2005072714A1 (fr) Administration orale de r-albuterol contre l'obesite
Kong et al. Calisthenics exercises to intervene in obesity and diabetes in middle-aged people
Yoo et al. Clinical trial of herbal formula on weight loss in obese Korean children
US6316499B1 (en) Methods for increasing the muscle mass of a human with materials derived from citrus varieties
Syed et al. Comparision of Efficacy and Safety of Orlistat vs Placebo in Obese Patients in Pakistan
Bondon-Guitton et al. Pulmonary arterial hypertension and benfluorex: 5 case reports
US6426096B1 (en) Anorexigenic composition
Shetty et al. Effect of short-term naturopathy and yoga intervention on anthropometric variables, lipid profile and thyroid profile in obese hypothyroid patients: a randomised controlled trial
Karabağ et al. The examination of the effect of caffeine supplementation in professional soccer players
Boscarino et al. The effect of operational stressors on ibuprofen pharmacokinetics

Legal Events

Date Code Title Description
FZDE Dead